BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261115
DTEND;VALUE=DATE:20261119
DTSTAMP:20261110T080858Z
CREATED:20260911T135953Z
LAST-MODIFIED:20261110T080858Z
UID:37420-1794700800-1795046399@senzagen.com
SUMMARY:ACT 2026
DESCRIPTION:American College of Toxicology (ACT) 47th Annual Meeting\n San Antonio\, USA\nAdvancing NAMs for Skin and Respiratory Sensitization Testing\nGARD®air for occupational health-related chemicals | Microorganisms | Proteins \nJoin us to discuss the latest developments in GARD® technology and explore how genomics- and machine learning-based approaches are supporting human-relevant sensitization assessment for product development and regulatory decision-making. \n \nPoster: Essential oils and quantitative potency assessment\nMonday\, 16 November\, 5:00 pm -6:30 pm \nDr Tim Lindberg | P204 | #2444913 – “Assessing skin sensitization potency and thresholds in Essential Oils: A comparative study using human data\, LLNA\, and GARD®skin Dose-Response” \n  \nNew: Immunotoxicology and biologics\nMonoclonal Antibodies | T-Cell Engagers | Bispecific Therapies \nWe are pleased to welcome Alcyomics to the SenzaGen Group\, expanding our capabilities in non-animal immunotoxicology and drug development\, with particular expertise in advanced biologics. \nRead more about Alcyomics
URL:https://senzagen.com/event/act2026/
LOCATION:San Antonio\, TX\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/09/ACT-am26-banner-event-page.png
END:VEVENT
END:VCALENDAR